143 related articles for article (PubMed ID: 32900459)
1. Reply to Letter to the Editor.
Meurer WJ; Barth B; Abraham M; Hoffman J; Vilke GM; DeMers G
J Emerg Med; 2020 Jul; 59(1):143. PubMed ID: 32900459
[No Abstract] [Full Text] [Related]
2. Author Reply to letter to the editor "Plasma ceramides are associated with outcomes in acute ischemic stroke patients".
Lee TH; Kuo CH; Tang SC
J Formos Med Assoc; 2021 Aug; 120(8):1661-1662. PubMed ID: 33858737
[No Abstract] [Full Text] [Related]
3. Impact of an emergency medicine pharmacist on time to thrombolysis in acute ischemic stroke: strength of association.
Safiri S; Sani M; Ayubi E
Am J Emerg Med; 2017 Feb; 35(2):345. PubMed ID: 27939515
[No Abstract] [Full Text] [Related]
4. Impact of an emergency medicine pharmacist on time to thrombolysis in acute ischemic stroke: strength of association.
Montgomery K; Hall AB
Am J Emerg Med; 2017 Feb; 35(2):345. PubMed ID: 27884583
[No Abstract] [Full Text] [Related]
5. Emergency Medicine Physicians Accurately Select Acute Stroke Patients for Tissue-Type Plasminogen Activator Treatment Using a Checklist.
Berekashvili K; Zha AM; Abdel-Al M; Zhang X; Soomro JH; Prater SJ; Grotta JC
Stroke; 2020 Feb; 51(2):663-665. PubMed ID: 31771461
[TBL] [Abstract][Full Text] [Related]
6. Tissue plasminogen activator for acute ischemic stroke: a New York city emergency medicine perspective.
Chan YF; Kwiatkowski TG; Rella JG; Rennie WP; Kwon RK; Silverman RA
J Emerg Med; 2005 Nov; 29(4):405-8. PubMed ID: 16243196
[TBL] [Abstract][Full Text] [Related]
7. In reply to the letter to the editor regarding: Sarcopenia is a predictor of patient death in acute ischemic stroke.
Surov A; Borggrefe J
J Stroke Cerebrovasc Dis; 2024 Apr; 33(4):107565. PubMed ID: 38214241
[No Abstract] [Full Text] [Related]
8. [Uncomplicated thrombolysis treatment with rt-PA via an intraosseous access after acute ischemic stroke].
Myftiu A; Hedtmann G; Kollmar R
Nervenarzt; 2020 Jun; 91(6):534-536. PubMed ID: 32347326
[No Abstract] [Full Text] [Related]
9. Emergency medicine residents in the implementation of thrombolysis for acute ischemic stroke.
Hälinen M; Mattila K; Janhunen H
Duodecim; 2016; 132(24):2342-48. PubMed ID: 29199794
[TBL] [Abstract][Full Text] [Related]
10. Author Response: Safety and Efficacy of Dual Antiplatelet Pretreatment in Patients With Ischemic Stroke Treated With IV Thrombolysis: A Systematic Review and Meta-analysis.
Katsanos AH; Tsivgoulis G
Neurology; 2021 Jan; 96(3):135. PubMed ID: 33462130
[No Abstract] [Full Text] [Related]
11. Reader Response: Safety and Efficacy of Dual Antiplatelet Pretreatment in Patients With Ischemic Stroke Treated With IV Thrombolysis: A Systematic Review and Meta-analysis.
Xu W; Hu X
Neurology; 2021 Jan; 96(3):134-135. PubMed ID: 33462129
[No Abstract] [Full Text] [Related]
12. In ischemic stroke, thrombectomy alone was noninferior to thrombectomy plus alteplase for functional outcome at 90 days.
Alberts MJ
Ann Intern Med; 2020 Sep; 173(6):JC31. PubMed ID: 32926812
[TBL] [Abstract][Full Text] [Related]
13. Economic benefit of increasing utilization of intravenous tissue plasminogen activator for acute ischemic stroke in the United States.
Scott PA; Silbergleit R
Stroke; 2006 Apr; 37(4):943-4; author reply 944. PubMed ID: 16567664
[No Abstract] [Full Text] [Related]
14. Pathophysiology of Ischemic Stroke: Role of Oxidative Stress.
Orellana-Urzúa S; Rojas I; Líbano L; Rodrigo R
Curr Pharm Des; 2020; 26(34):4246-4260. PubMed ID: 32640953
[TBL] [Abstract][Full Text] [Related]
15. Barriers to administering intravenous tissue plasminogen activator (tPA) for acute ischemic stroke in the emergency department: A cross-sectional survey of stroke centers.
Hargis M; Shah JN; Mazabob J; Rao CV; Suarez JI; Bershad EM
Clin Neurol Neurosurg; 2015 Aug; 135():79-84. PubMed ID: 26047090
[TBL] [Abstract][Full Text] [Related]
16. Letter by Wu et al Regarding Article, "Intravenous Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients With History of Stroke Plus Diabetes Mellitus".
Wu C; Ma H; Ji X
Stroke; 2019 Sep; 50(9):e271. PubMed ID: 31370768
[No Abstract] [Full Text] [Related]
17. Multimodal imaging selection for IV alteplase in unknown time of onset stroke: Are we there yet?
Urrutia VC
Neurology; 2020 Dec; 95(22):989-990. PubMed ID: 33097600
[No Abstract] [Full Text] [Related]
18. Recombinant tissue plasminogen activator for acute ischemic stroke.
Al-Buhairi AR; Jan MM
Saudi Med J; 2002 Jan; 23(1):13-9. PubMed ID: 11938357
[TBL] [Abstract][Full Text] [Related]
19. Response to letter regarding article, "Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion".
Coutts SB; Hill MD
Stroke; 2015 Jun; 46(6):e150. PubMed ID: 25899240
[No Abstract] [Full Text] [Related]
20. Evidence-based emergency medicine. Feedback: "think or die!".
Green WL
Ann Emerg Med; 2000 Sep; 36(3):253-4. PubMed ID: 10969232
[No Abstract] [Full Text] [Related]
[Next] [New Search]
